Fisker (FSR) to Enter India Market with Ocean and PEAR

Go back to Fisker (FSR) to Enter India Market with Ocean and PEAR

Fisker (FSR) Partners with Wallbox (WBX) for EV Charging

September 20, 2022 11:19 AM EDT

Sustainable Electric Vehicle manufacturer, Fisker Inc. (NYSE: FSR) announced a partnership with energy management company, Wallbox (NYSE: WBX) for home EV charging solutions.

The partnership will allow Fisker to offer its EV customers Wallbox home EV chargers for purchase through the Fisker website in the U.S., Canada, and European launch markets. The Pulsar Plus, Wallbox's best-selling... More

Pre-Open Movers: Adobe Sinks on Deal to Acquire Figma, STOR Surges on Takeover

September 15, 2022 9:17 AM EDT

Pre-Open Stock Movers:

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) 48% LOWER; announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation. The combination trial of ELX-02 with ivacaftor was well tolerated but did not achieve statistical significance for efficacy endpoints, including changes from baseline in sweat chloride concentration (SCC) and percent forced expiratory volume (FEV1).

IronNet (NYSE: IRNT) 44% LOWER;... More

Fisker (FSR) Climbs Following New Buy Rating

September 15, 2022 8:50 AM EDT

Fisker (NYSE: FSR) climbed prior to the bell Thursday following a new Buy rating from Needham. Shares were up about 5.5%.

... More

After-Hours Movers: Danaher Jumps on Spinoff Plans, Arconic Sinks on Lower Outlook

September 14, 2022 5:58 PM EDT

After-Hours Stock Movers:

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) 48% LOWER; announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation. The combination trial of ELX-02 with ivacaftor was well tolerated but did not achieve statistical significance for efficacy endpoints, including changes from baseline in sweat chloride concentration (SCC) and percent forced expiratory volume... More

Needham Upgrades Tesla to Hold, Launches Coverage on 3 Other EV Stocks

September 14, 2022 5:19 PM EDT

Needham & Company has a new EV analyst, Vikram Bagri, who took over coverage of Tesla (NASDAQ: TSLA) and upgraded the shares to Hold from Underperform and launched coverage on three other EV stocks Fisker (Buy), Rivian (Hold), and Lucid (Underperform).

Tesla (NASDAQ: TSLA) was upgraded to hold from underperform. The analysts mentioned the following potential catalysts that could drive the stock higher: (1) renewed federal tax credit eligibility under... More

UPDATE: Needham & Company Assumes Fisker (FSR) at Buy

September 14, 2022 4:10 PM EDT

(Updated - September 14, 2022 4:11 PM EDT)

Needham & Company analyst Vikram Bagri assumes coverage on Fisker (NYSE: FSR) with a Buy rating, PT $12.

The analyst comments "We are initiating coverage on Fisker (FSR) with a Buy rating and $12 PT. FSR is entering... More